SHC
Sotera Health Co
Company overview
- Market capitalization
- $5.27B
- Employees
- 3,000
- Latest publication
- 2026-09-29
About Sotera Health Co
Sotera Health Company provides sterilization solutions, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for medical devices, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 321,375,000USD | 280,045,000USD | 303,441,000USD | 311,312,000USD | 294,341,000USD | 254,523,000USD | 290,203,000USD | 285,468,000USD |
| Cost Of Revenue | 143,412,000USD | 136,007,000USD | 137,521,000USD | 133,751,000USD | 127,720,000USD | 119,091,000USD | 125,838,000USD | 127,444,000USD |
| Gross Profit | 177,963,000USD | 144,038,000USD | 165,920,000USD | 177,561,000USD | 166,621,000USD | 135,432,000USD | 164,365,000USD | 158,024,000USD |
| Selling General Administrative | 68,156,000USD | 68,211,000USD | 57,514,000USD | 63,294,000USD | 68,893,000USD | 63,061,000USD | 61,837,000USD | 62,009,000USD |
| Total Operating Expenses | 68,156,000USD | 57,399,000USD | 29,799,000USD | 66,384,000USD | 78,191,000USD | 78,388,000USD | 77,219,000USD | 77,517,000USD |
| Operating Income | 109,807,000USD | 86,639,000USD | 136,121,000USD | 111,177,000USD | 88,430,000USD | 57,044,000USD | 87,146,000USD | 80,507,000USD |
| Total Other Income Expense Net | -31,756,000USD | -44,026,000USD | -65,624,000USD | -38,242,000USD | -69,533,000USD | -71,867,000USD | -42,182,000USD | -37,753,000USD |
| Income Before Tax | 78,051,000USD | 42,613,000USD | 70,497,000USD | 72,935,000USD | 18,897,000USD | -14,823,000USD | 44,964,000USD | 42,754,000USD |
| Income Tax Expense | 24,408,000USD | 16,024,000USD | 35,650,000USD | 24,535,000USD | 10,935,000USD | -1,563,000USD | 32,641,000USD | 25,756,000USD |
| Net Income | 53,643,000USD | 26,589,000USD | 34,847,000USD | 48,400,000USD | 7,962,000USD | -13,260,000USD | 12,323,000USD | 16,998,000USD |
| Net Income Applicable To Common Shares | 53,643,000USD | — | — | — | — | — | — | — |
| Unclassified Operating Expenses | — | -10,812,000USD | -27,715,000USD | 3,090,000USD | 9,298,000USD | 15,327,000USD | 15,382,000USD | 15,508,000USD |
| Interest Expense | — | 34,745,000USD | 35,048,000USD | 39,147,000USD | 40,651,000USD | 40,876,000USD | 40,960,000USD | 41,572,000USD |
| Net Interest Income | — | -34,745,000USD | -35,048,000USD | -39,147,000USD | -40,651,000USD | -40,876,000USD | -40,960,000USD | -41,572,000USD |
| Tax Provision | — | 16,024,000USD | 35,650,000USD | 24,535,000USD | 10,935,000USD | -1,563,000USD | 32,641,000USD | 25,756,000USD |
| Net Income From Continuing Ops | — | 26,589,000USD | 34,847,000USD | 48,400,000USD | 7,962,000USD | -13,260,000USD | 12,323,000USD | 16,998,000USD |
| Ebit | — | 86,639,000USD | 105,545,000USD | 112,082,000USD | 59,633,000USD | 26,053,000USD | 85,924,000USD | 84,326,000USD |
| Ebitda | — | 118,126,000USD | 146,349,000USD | 138,415,000USD | 95,213,000USD | 66,857,000USD | 126,236,000USD | 127,391,000USD |
| Depreciation And Amortization | — | 31,487,000USD | 40,804,000USD | 26,333,000USD | 35,580,000USD | 40,804,000USD | 40,312,000USD | 43,065,000USD |
| Reconciled Depreciation | — | 30,814,000USD | 32,526,000USD | 28,360,000USD | 35,016,000USD | 40,804,000USD | 40,312,000USD | 43,065,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,163,617,000USD | 1,100,441,000USD | 1,049,288,000USD | 1,003,687,000USD | 931,478,000USD | 818,158,000USD | 778,327,000USD | 746,149,000USD |
| Cost Of Revenue | 518,083,000USD | 498,146,000USD | 472,130,000USD | 446,683,000USD | 412,806,000USD | 374,586,000USD | 382,896,000USD | 388,897,000USD |
| Gross Profit | 645,534,000USD | 602,295,000USD | 577,158,000USD | 557,004,000USD | 518,672,000USD | 443,572,000USD | 395,431,000USD | 357,252,000USD |
| Selling General Administrative | 252,762,000USD | 242,630,000USD | 242,258,000USD | 245,714,000USD | 198,158,000USD | 178,525,000USD | 147,480,000USD | 133,363,000USD |
| Total Operating Expenses | 252,762,000USD | 304,669,000USD | 300,466,000USD | 308,654,000USD | 261,939,000USD | 237,554,000USD | 211,834,000USD | 191,338,000USD |
| Operating Income | 392,772,000USD | 297,626,000USD | 276,692,000USD | 248,350,000USD | 256,733,000USD | 206,018,000USD | 183,597,000USD | 80,847,000USD |
| Interest Expense | 155,722,000USD | 164,691,000USD | 142,878,000USD | 80,144,000USD | 74,192,000USD | 215,259,000USD | 157,729,000USD | 143,326,000USD |
| Net Interest Income | -155,722,000USD | -164,691,000USD | -132,494,000USD | -80,144,000USD | -74,192,000USD | -215,259,000USD | -157,729,000USD | -143,326,000USD |
| Income Before Tax | 147,506,000USD | 113,874,000USD | 106,027,000USD | -243,111,000USD | 175,716,000USD | -38,860,000USD | -916,000USD | 24,222,000USD |
| Income Tax Expense | 69,557,000USD | 69,476,000USD | 54,651,000USD | -9,541,000USD | 58,595,000USD | -1,369,000USD | 19,509,000USD | 30,098,000USD |
| Tax Provision | 69,557,000USD | 69,476,000USD | -31,121,000USD | -9,541,000USD | 58,595,000USD | -1,369,000USD | 19,509,000USD | 30,098,000USD |
| Net Income | 77,949,000USD | 44,398,000USD | 51,376,000USD | -233,570,000USD | 116,882,000USD | -38,617,000USD | -20,850,000USD | -5,870,000USD |
| Net Income From Continuing Ops | 77,949,000USD | 44,398,000USD | -307,024,000USD | -233,570,000USD | 117,121,000USD | -37,491,000USD | -20,425,000USD | -5,876,000USD |
| Ebitda | 303,228,000USD | 442,202,000USD | 406,830,000USD | -17,413,000USD | 400,810,000USD | 319,962,000USD | 303,532,000USD | 314,364,000USD |
| Reconciled Depreciation | 136,706,000USD | 163,637,000USD | 153,665,000USD | 145,554,000USD | 63,781,000USD | 143,563,000USD | 146,719,000USD | 146,816,000USD |
| Total Other Income Expense Net | -245,266,000USD | -183,752,000USD | -170,665,000USD | -491,461,000USD | -81,017,000USD | -244,878,000USD | -184,513,000USD | -56,625,000USD |
| Unclassified Operating Expenses | — | 62,039,000USD | 58,208,000USD | 62,940,000USD | 63,781,000USD | 59,029,000USD | 64,354,000USD | 57,975,000USD |
| Ebit | — | 278,565,000USD | 248,905,000USD | -162,967,000USD | 249,908,000USD | 176,399,000USD | 156,813,000USD | 167,548,000USD |
| Depreciation And Amortization | — | 163,637,000USD | 157,925,000USD | 145,554,000USD | 150,902,000USD | 143,563,000USD | 146,719,000USD | 146,816,000USD |
| Minority Interest | — | — | 0USD | 0USD | -239,000USD | 15,897,000USD | 15,067,000USD | 14,757,000USD |
| Net Income Applicable To Common Shares | — | — | — | -233,570,000USD | 116,882,000USD | -38,617,000USD | -20,850,000USD | -5,870,000USD |
| Non Operating Income Net Other | — | — | — | — | -6,825,000USD | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,306,790,000USD | 3,235,898,000USD | 3,263,190,000USD | 3,186,162,000USD | 3,216,729,000USD | 3,097,528,000USD | 3,071,648,000USD | 3,148,737,000USD |
| Cash And Equivalents | 356,716,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 646,458,000USD | 585,971,000USD | 613,410,000USD | 577,815,000USD | 608,175,000USD | 554,990,000USD | 526,037,000USD | 563,613,000USD |
| Other Current Assets | 9,676,000USD | 30,866,000USD | 36,313,000USD | 26,646,000USD | 36,001,000USD | 36,409,000USD | 33,827,000USD | 26,615,000USD |
| Other Non Current Assets | 40,632,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 2,641,142,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 231,238,000USD | 207,804,000USD | 249,584,000USD | 242,399,000USD | 246,320,000USD | 225,991,000USD | 191,002,000USD | 195,537,000USD |
| Other Current Liabilities | 83,573,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 5,376,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 665,648,000USD | 622,505,000USD | 606,035,000USD | 550,471,000USD | 511,283,000USD | 414,091,000USD | 404,911,000USD | 470,163,000USD |
| Total Equity Including Noncontrolling Interest | 665,648,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 27,846,000USD | 13,983,000USD | 13,973,000USD | 13,964,000USD | 14,820,000USD | 14,811,000USD | 14,803,000USD | 14,795,000USD |
| Long Term Debt | 2,125,534,000USD | 2,124,327,000USD | 2,126,724,000USD | 2,128,996,000USD | 2,202,651,000USD | 2,205,355,000USD | 2,208,100,000USD | 2,210,815,000USD |
| Deferred Revenue | 14,212,000USD | — | — | — | — | — | — | — |
| Net Receivables | 150,538,000USD | 176,322,000USD | 176,266,000USD | 195,169,000USD | 179,788,000USD | 153,146,000USD | 165,810,000USD | 176,613,000USD |
| Inventory | 56,372,000USD | 62,838,000USD | 54,375,000USD | 54,974,000USD | 59,949,000USD | 61,045,000USD | 49,158,000USD | 53,647,000USD |
| Property Plant Equipment Net | 1,198,586,000USD | 1,176,348,000USD | 1,163,957,000USD | 1,128,399,000USD | 1,111,923,000USD | 1,073,521,000USD | 1,064,443,000USD | 1,055,294,000USD |
| Goodwill | 1,091,255,000USD | — | — | — | — | — | — | — |
| Intangible Assets | 270,171,000USD | 279,357,000USD | 288,227,000USD | 290,856,000USD | 300,109,000USD | 300,300,000USD | 317,653,000USD | 351,977,000USD |
| Accounts Payable | 101,018,000USD | 76,688,000USD | 77,963,000USD | 61,388,000USD | 63,660,000USD | 70,106,000USD | 55,098,000USD | 70,754,000USD |
| Short Term Debt | 5,472,000USD | 23,348,000USD | 23,193,000USD | 22,900,000USD | 23,655,000USD | 22,934,000USD | 22,782,000USD | 22,904,000USD |
| Common Stock | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,860,000USD |
| Retained Earnings | -451,861,000USD | -505,504,000USD | -532,093,000USD | -566,940,000USD | -615,340,000USD | -623,302,000USD | -610,042,000USD | -622,365,000USD |
| Accumulated Other Comprehensive Income | -143,455,000USD | -125,939,999USD | -109,838,000USD | -125,506,999USD | -108,288,000USD | -189,453,000USD | -208,251,000USD | -124,619,000USD |
| Total Liab | — | 2,613,393,000USD | 2,657,155,000USD | 2,635,691,000USD | 2,705,446,000USD | 2,683,437,000USD | 2,666,737,000USD | 2,678,574,000USD |
| Other Current Liab | — | 107,768,000USD | 148,428,000USD | 144,051,000USD | 141,332,000USD | 111,469,000USD | 86,540,000USD | 80,401,000USD |
| Capital Stock | — | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,860,000USD |
| Good Will | — | 1,097,634,000USD | 1,103,232,000USD | 1,098,975,000USD | 1,104,502,000USD | 1,084,382,000USD | 1,081,073,000USD | 1,104,555,000USD |
| Cash | — | 315,945,000USD | 346,456,000USD | 301,026,000USD | 332,437,000USD | 304,390,000USD | 277,242,000USD | 306,738,000USD |
| Cash And Short Term Investments | — | 315,945,000USD | 346,456,000USD | 301,026,000USD | 332,437,000USD | 304,390,000USD | 277,242,000USD | 306,738,000USD |
| Net Debt | — | 1,954,312,000USD | 1,927,197,000USD | 1,976,351,000USD | 2,017,277,000USD | 2,042,094,000USD | 2,073,391,000USD | 2,050,868,000USD |
| Short Long Term Debt Total | — | 2,270,257,000USD | 2,273,653,000USD | 2,277,377,000USD | 2,349,714,000USD | 2,346,484,000USD | 2,350,633,000USD | 2,357,606,000USD |
| Property Plant Equipment Gross | — | 1,176,348,000USD | 1,835,816,000USD | 1,128,399,000USD | 1,111,923,000USD | 1,073,521,000USD | 1,626,856,000USD | 1,055,294,000USD |
| Common Stock Shares Outstanding | — | 287,622,000shares | 286,421,000shares | 286,745,000shares | 285,756,000shares | 283,558,000shares | 284,906,000shares | 285,564,000shares |
| Non Current Assets Total | — | 2,649,927,000USD | 2,649,780,000USD | 2,608,346,999USD | 2,608,554,000USD | 2,542,538,000USD | 2,545,611,000USD | 2,585,124,000USD |
| Non Current Liabilities Total | — | 2,405,589,000USD | 2,407,571,000USD | 2,393,292,000USD | 2,459,126,000USD | 2,457,446,000USD | 2,475,735,000USD | 2,483,037,000USD |
| Non Current Liabilities Other | — | 5,152,000USD | 7,360,000USD | 7,031,000USD | 7,150,000USD | 5,474,000USD | 4,418,000USD | 9,285,000USD |
| Non Currrent Assets Other | — | 92,819,000USD | 94,364,000USD | 86,892,999USD | 87,554,000USD | 81,356,000USD | 79,577,000USD | 68,352,000USD |
| Net Working Capital | — | 378,167,000USD | 363,826,000USD | 335,416,000USD | 361,855,000USD | 328,999,000USD | 335,035,000USD | 368,076,000USD |
| Unclassified Current Liabilities | — | -13,983,000USD | -13,973,000USD | -13,964,000USD | -8,673,000USD | -7,083,000USD | -3,321,000USD | -3,970,000USD |
| Unclassified Non Current Liabilities | — | 276,110,000USD | 273,487,000USD | 257,265,000USD | 249,325,000USD | 246,617,000USD | 263,217,000USD | 262,937,000USD |
| Unclassified Equity | — | 1,248,228,999USD | 1,242,246,000USD | 1,237,197,999USD | 1,229,191,000USD | 1,221,126,000USD | 1,217,484,000USD | 1,211,427,000USD |
| Current Deferred Revenue | — | — | — | 14,060,000USD | 11,526,000USD | 13,754,000USD | 15,100,000USD | 10,653,000USD |
| Short Term Investments | — | — | — | 215,000USD | — | — | 1,623,000USD | 1,744,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 3,263,190,000USD | 3,071,648,000USD | 3,130,420,000USD | 3,117,705,000USD | 2,789,502,000USD | 2,761,279,000USD | 2,580,674,000USD | 2,708,584,000USD |
| Intangible Assets | 288,227,000USD | 317,653,000USD | 416,318,000USD | 491,265,000USD | 598,844,000USD | 643,366,000USD | 696,006,000USD | 766,054,000USD |
| Other Current Assets | 36,313,000USD | 33,827,000USD | 37,002,000USD | 56,934,000USD | 50,709,000USD | 47,456,000USD | 40,513,000USD | 37,379,000USD |
| Total Liab | 2,657,155,000USD | 2,666,737,000USD | 2,686,686,000USD | 2,767,467,000USD | 2,203,406,000USD | 2,306,705,000USD | 3,221,806,000USD | 2,663,093,000USD |
| Total Stockholder Equity | 606,035,000USD | 404,911,000USD | 443,734,000USD | 350,238,000USD | 586,096,000USD | 452,302,000USD | -642,574,000USD | 44,359,000USD |
| Other Current Liab | 148,428,000USD | 86,540,000USD | 120,064,000USD | 490,459,000USD | 60,271,000USD | 58,539,000USD | 58,373,000USD | 73,058,000USD |
| Common Stock | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,324,000USD | 2,324,000USD |
| Capital Stock | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,860,000USD | 2,324,000USD | 2,324,000USD |
| Retained Earnings | -532,093,000USD | -610,042,000USD | -654,440,000USD | -705,816,000USD | -472,246,000USD | -589,128,000USD | -550,511,000USD | -10,417,000USD |
| Good Will | 1,103,232,000USD | 1,081,073,000USD | 1,111,190,000USD | 1,101,768,000USD | 1,120,320,000USD | 1,115,936,000USD | 1,035,865,000USD | 1,023,314,000USD |
| Cash | 346,456,000USD | 277,242,000USD | 296,407,000USD | 395,214,000USD | 106,917,000USD | 102,447,000USD | 62,863,000USD | 96,272,000USD |
| Cash And Short Term Investments | 346,456,000USD | 277,242,000USD | 296,407,000USD | 395,214,000USD | 106,917,000USD | 102,447,000USD | 62,863,000USD | 96,272,000USD |
| Total Current Assets | 613,410,000USD | 526,037,000USD | 557,244,000USD | 645,010,000USD | 345,961,000USD | 315,015,000USD | 252,354,000USD | 312,862,000USD |
| Total Current Liabilities | 249,584,000USD | 191,002,000USD | 230,654,000USD | 791,567,000USD | 161,161,000USD | 140,598,000USD | 123,990,000USD | 143,374,000USD |
| Net Debt | 1,927,197,000USD | 2,073,391,000USD | 2,030,649,000USD | 1,636,828,000USD | 1,720,960,000USD | 1,806,778,000USD | 2,785,512,000USD | 2,141,521,000USD |
| Short Term Debt | 23,193,000USD | 22,782,000USD | 19,502,000USD | 206,395,000USD | 10,449,000USD | 10,556,000USD | 17,619,000USD | 16,695,000USD |
| Short Long Term Debt | 13,973,000USD | 14,803,000USD | 4,797,000USD | 197,119,000USD | — | — | 16,331,000USD | 15,343,000USD |
| Short Long Term Debt Total | 2,273,653,000USD | 2,350,633,000USD | 2,327,056,000USD | 2,032,042,000USD | 1,827,877,000USD | 1,909,225,000USD | 2,848,375,000USD | 2,237,793,000USD |
| Long Term Debt | 2,126,724,000USD | 2,208,100,000USD | 2,223,674,000USD | 1,747,115,000USD | 1,743,534,000USD | 1,824,789,000USD | 2,800,873,000USD | 2,189,563,000USD |
| Net Receivables | 176,266,000USD | 165,810,000USD | 175,519,000USD | 155,717,000USD | 134,047,000USD | 131,019,000USD | 111,582,000USD | 141,612,000USD |
| Inventory | 54,375,000USD | 49,158,000USD | 48,316,000USD | 37,145,000USD | 54,288,000USD | 34,093,000USD | 37,396,000USD | 37,599,000USD |
| Accounts Payable | 77,963,000USD | 55,098,000USD | 71,039,000USD | 74,139,000USD | 72,868,000USD | 52,400,000USD | 42,004,000USD | 46,355,000USD |
| Property Plant Equipment Net | 1,163,957,000USD | 1,064,443,000USD | 970,951,000USD | 801,008,000USD | 690,743,000USD | 655,777,000USD | 581,954,000USD | 586,436,000USD |
| Property Plant Equipment Gross | 1,835,816,000USD | 1,626,856,000USD | 1,475,728,000USD | 801,008,000USD | 690,743,000USD | 655,777,000USD | 581,954,000USD | 586,436,000USD |
| Accumulated Other Comprehensive Income | -109,838,000USD | -208,251,000USD | -92,682,000USD | -106,653,000USD | -83,566,000USD | -93,842,000USD | -94,387,000USD | -109,957,000USD |
| Common Stock Shares Outstanding | 286,421,000shares | 284,906,000shares | 283,222,000shares | 280,096,000shares | 279,382,000shares | 283,248,000shares | 284,421,755shares | 246,152,000shares |
| Non Current Assets Total | 2,649,780,000USD | 2,545,611,000USD | 2,573,176,000USD | 2,472,695,000USD | 2,443,541,000USD | 2,446,264,000USD | 2,328,320,000USD | 2,395,722,000USD |
| Non Current Liabilities Total | 2,407,571,000USD | 2,475,735,000USD | 2,456,032,000USD | 1,975,900,000USD | 2,042,245,000USD | 2,166,107,000USD | 3,097,816,000USD | 2,519,719,000USD |
| Non Current Liabilities Other | 7,360,000USD | 4,418,000USD | 8,879,000USD | 12,831,000USD | 164,210,000USD | 17,506,000USD | 20,563,000USD | 32,605,000USD |
| Non Currrent Assets Other | 94,364,000USD | 79,577,000USD | 69,724,000USD | 74,553,000USD | 18,344,000USD | 9,304,000USD | 12,243,000USD | 4,154,000USD |
| Net Working Capital | 363,826,000USD | 335,035,000USD | 326,590,000USD | -146,557,000USD | 184,800,000USD | 174,417,000USD | 128,364,000USD | 169,488,000USD |
| Unclassified Current Liabilities | -13,973,000USD | -3,321,000USD | — | -188,685,000USD | 8,904,000USD | 13,047,000USD | -13,968,000USD | -12,692,000USD |
| Unclassified Non Current Liabilities | 273,487,000USD | 263,217,000USD | 223,479,000USD | 65,701,000USD | -298,711,000USD | 69,999,000USD | — | — |
| Unclassified Equity | 1,242,246,000USD | 1,217,484,000USD | 1,185,136,000USD | 1,156,987,000USD | 1,169,733,000USD | 1,129,552,000USD | — | 160,085,000USD |
| Current Deferred Revenue | — | 15,100,000USD | 13,492,000USD | 12,140,000USD | 8,669,000USD | 6,056,000USD | 3,631,000USD | 4,615,000USD |
| Short Term Investments | — | — | 715,000USD | 660,000USD | 623,000USD | 673,000USD | 5,060,000USD | 4,800,000USD |
| Other Liab | — | — | — | 150,253,000USD | 298,711,000USD | 253,813,000USD | 253,435,000USD | 284,996,000USD |
| Other Assets | — | — | — | 82,909,000USD | 33,634,000USD | 77,148,000USD | 18,808,000USD | 23,471,000USD |
| Long Term Investments | — | — | — | 0USD | 9,405,000USD | 13,457,000USD | 0USD | — |
| Net Tangible Assets | — | — | — | -1,242,795,000USD | -1,133,068,000USD | -1,307,000,000USD | -2,374,445,000USD | -1,745,009,000USD |
| Unclassified Non Current Assets | — | — | — | -78,808,000USD | -27,749,000USD | -68,724,000USD | — | — |
| Deferred Long Term Liab | — | — | — | — | 134,501,000USD | — | — | — |
| Treasury Stock | — | — | — | — | -33,545,000USD | — | — | — |
| Unclassified Current Assets | — | — | — | — | — | — | -5,060,000USD | -4,800,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Stock Based Compensation | 21,611,000USD |
| Deferred Income Tax | 13,796,000USD |
| Other Non Cash Items | 2,570,000USD |
| Change To Account Receivables | -13,256,000USD |
| Change To Inventory | -4,121,000USD |
| Change To Liabilities | 2,250,000USD |
| Change In Working Capital | -7,153,000USD |
| Operating Cash Flow | 117,930,000USD |
| Capital Expenditures | -92,615,000USD |
| Other Investing Activities | -4,188,000USD |
| Unclassified Investing Cash Flow | 8,376,000USD |
| Investing Cash Flow | -88,427,000USD |
| Net Debt Issuance | -3,558,000USD |
| Net Common Stock Issuance | -9,074,000USD |
| Other Financing Activities | -1,674,000USD |
| Unclassified Financing Cash Flow | -878,000USD |
| Financing Cash Flow | -15,184,000USD |
| Effect Of Forex Changes On Cash | -4,048,000USD |
| Change In Cash | 10,271,000USD |
| End Cash Flow | 356,727,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 26,589,000USD | 34,847,000USD | 48,400,000USD | 7,962,000USD | -13,260,000USD | 12,317,000USD | 16,988,000USD | 8,754,000USD |
| Depreciation | 31,487,000USD | 32,456,000USD | 28,290,000USD | 35,016,000USD | 40,804,000USD | 39,548,000USD | 42,551,000USD | 39,830,000USD |
| Stock Based Compensation | 14,393,000USD | 7,603,000USD | 8,047,000USD | 8,119,000USD | 7,242,000USD | 8,144,000USD | 9,789,000USD | 10,181,000USD |
| Other Non Cash Items | 13,296,000USD | 54,080,000USD | 47,564,000USD | -20,003,000USD | 39,310,000USD | -9,256,000USD | -331,000USD | 22,633,000USD |
| Change To Account Receivables | 891,000USD | 4,495,000USD | -6,428,000USD | -4,546,000USD | 13,630,000USD | -14,026,000USD | -6,019,000USD | -18,308,000USD |
| Change To Inventory | -4,088,000USD | -3,754,000USD | 9,040,000USD | 4,176,000USD | -11,839,000USD | 1,470,000USD | 4,861,000USD | -7,032,000USD |
| Change In Working Capital | -46,104,000USD | 8,510,000USD | -14,340,000USD | 35,346,000USD | 29,471,000USD | -2,578,000USD | 16,616,000USD | -15,445,000USD |
| Total Cash From Operating Activities | 29,435,000USD | 102,649,000USD | 69,561,000USD | 57,416,000USD | 55,521,000USD | 55,717,000USD | 95,603,000USD | 61,295,000USD |
| Capital Expenditures | -46,166,000USD | -50,699,000USD | -36,172,000USD | -31,229,000USD | -19,918,000USD | -65,870,000USD | -36,389,000USD | -41,921,000USD |
| Free Cash Flow | -16,731,000USD | 51,950,000USD | 33,389,000USD | 26,187,000USD | 35,603,000USD | -10,153,000USD | 59,214,000USD | 19,374,000USD |
| Total Cashflows From Investing Activities | -45,128,000USD | -50,699,000USD | -33,335,000USD | -31,229,000USD | -19,881,000USD | -65,870,000USD | -36,352,000USD | -41,921,000USD |
| Net Borrowings | -3,558,000USD | -3,557,000USD | -75,000,000USD | -3,774,000USD | -3,773,000USD | -3,773,000USD | 0USD | — |
| Total Cash From Financing Activities | -12,779,000USD | -7,720,000USD | -75,746,000USD | -6,933,000USD | -8,087,000USD | -6,548,000USD | -804,000USD | -29,421,000USD |
| Change In Cash | -30,511,000USD | 45,430,000USD | -33,246,000USD | 28,191,000USD | 27,216,000USD | -29,617,000USD | 60,724,000USD | -15,062,000USD |
| Begin Period Cash Flow | 346,456,000USD | 301,026,000USD | 334,272,000USD | 306,081,000USD | 278,865,000USD | 308,482,000USD | 247,758,000USD | 262,820,000USD |
| End Period Cash Flow | 315,945,000USD | 346,456,000USD | 301,026,000USD | 334,272,000USD | 306,081,000USD | 278,865,000USD | 308,482,000USD | 247,758,000USD |
| Other Cashflows From Investing Activities | 1,038,000USD | — | 2,837,000USD | — | 37,000USD | — | 37,000USD | — |
| Other Cashflows From Financing Activities | -9,221,000USD | -4,163,000USD | -746,000USD | -3,105,000USD | -714,000USD | 1,653,000USD | -804,000USD | -29,421,000USD |
| Unclassified Operating Cash Flow | -10,226,000USD | -34,847,000USD | -48,400,000USD | -9,024,000USD | -48,046,000USD | 7,542,000USD | 9,990,000USD | -4,658,000USD |
| Investments | — | — | -33,335,000USD | -31,229,000USD | -19,881,000USD | -65,870,000USD | -36,352,000USD | -41,921,000USD |
| Unclassified Investing Cash Flow | — | — | 33,335,000USD | 31,229,000USD | 19,881,000USD | 65,870,000USD | 36,352,000USD | 41,921,000USD |
| Sale Purchase Of Stock | — | — | — | -54,000USD | -3,600,000USD | -4,428,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 77,949,000USD | 44,398,000USD | 51,376,000USD | -233,570,000USD | 117,121,000USD | -37,491,000USD | -20,425,000USD | -5,876,000USD |
| Depreciation | 136,706,000USD | 163,637,000USD | 160,338,000USD | 145,554,000USD | 150,902,000USD | 143,563,000USD | 146,719,000USD | 146,816,000USD |
| Stock Based Compensation | 30,878,000USD | 36,777,000USD | 32,238,000USD | 21,211,000USD | 13,870,000USD | 10,987,000USD | 6,882,000USD | 6,943,000USD |
| Other Non Cash Items | 181,202,000USD | 12,553,000USD | 8,152,000USD | 9,492,000USD | 15,959,000USD | 38,679,000USD | 43,209,000USD | 12,962,000USD |
| Change To Account Receivables | 7,151,000USD | 2,216,000USD | -21,724,000USD | -12,555,000USD | -15,509,000USD | 1,942,000USD | 11,764,000USD | -2,906,000USD |
| Change To Inventory | -2,377,000USD | -4,753,000USD | -9,972,000USD | 14,441,000USD | -20,245,000USD | 3,784,000USD | -282,000USD | -7,041,000USD |
| Change In Working Capital | 28,044,000USD | -42,634,000USD | -403,285,000USD | 409,234,000USD | -12,591,000USD | -11,793,000USD | -8,351,000USD | 4,035,000USD |
| Total Cash From Operating Activities | 287,195,000USD | 224,164,000USD | -147,732,000USD | 277,961,000USD | 281,545,000USD | 120,585,000USD | 149,041,000USD | 119,563,000USD |
| Capital Expenditures | -138,018,000USD | -179,070,000USD | -214,975,000USD | -182,378,000USD | -102,162,000USD | -53,507,000USD | -57,257,000USD | -72,613,000USD |
| Free Cash Flow | 149,177,000USD | 45,094,000USD | -362,707,000USD | 95,583,000USD | 179,383,000USD | 67,078,000USD | 91,784,000USD | 46,950,000USD |
| Total Cashflows From Investing Activities | -135,144,000USD | -178,996,000USD | -214,906,000USD | -181,896,000USD | -159,833,000USD | -158,694,000USD | -57,257,000USD | 96,638,000USD |
| Net Borrowings | -86,104,000USD | -11,759,000USD | 297,500,000USD | 200,000,000USD | -100,000,000USD | -1,027,325,000USD | 583,516,000USD | -14,634,000USD |
| Total Cash From Financing Activities | -100,534,000USD | -50,564,000USD | 265,959,000USD | 197,761,000USD | -117,286,000USD | 73,432,000USD | -126,030,000USD | -191,857,000USD |
| Change In Cash | 67,591,000USD | -22,789,000USD | -94,640,000USD | 289,370,000USD | 4,470,000USD | 39,429,000USD | -33,761,000USD | 20,668,000USD |
| Begin Period Cash Flow | 278,865,000USD | 301,654,000USD | 396,294,000USD | 106,924,000USD | 102,454,000USD | 63,025,000USD | 96,786,000USD | 76,118,000USD |
| End Period Cash Flow | 346,456,000USD | 278,865,000USD | 301,654,000USD | 396,294,000USD | 106,924,000USD | 102,454,000USD | 63,025,000USD | 96,786,000USD |
| Other Cashflows From Investing Activities | 2,874,000USD | 74,000USD | 69,000USD | 32,000USD | -701,000USD | -701,000USD | -701,000USD | 6,429,000USD |
| Other Cashflows From Financing Activities | -14,430,000USD | -34,377,000USD | -27,452,000USD | -1,846,000USD | -15,852,000USD | 278,796,000USD | 3,126,224,000USD | -1,378,000USD |
| Unclassified Operating Cash Flow | -167,584,000USD | 9,433,000USD | 3,449,000USD | -73,960,000USD | -3,716,000USD | -23,360,000USD | -18,993,000USD | -45,317,000USD |
| Investments | — | -178,996,000USD | -221,818,000USD | -181,896,000USD | -159,833,000USD | -158,694,000USD | -57,257,000USD | 96,638,000USD |
| Sale Purchase Of Stock | — | -4,428,000USD | -4,089,000USD | -393,000USD | -1,434,000USD | -34,000,000USD | — | — |
| Unclassified Investing Cash Flow | — | 178,996,000USD | 221,818,000USD | 182,346,000USD | 102,863,000USD | 54,208,000USD | 57,958,000USD | 66,184,000USD |
| Change To Liabilities | — | — | — | 1,107,000USD | 31,091,000USD | -6,022,000USD | -8,968,000USD | 15,125,000USD |
| Issuance Of Capital Stock | — | — | — | 0USD | 0USD | 1,155,961,000USD | 0USD | — |
| Dividends Paid | — | — | — | — | 0USD | -150,000,000USD | -691,170,000USD | -175,845,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | 4,426,000USD | — | — | — |
| Unclassified Financing Cash Flow | — | — | — | — | — | 1,005,961,000USD | -3,144,600,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Product | Product | 43,050,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Product | Services | 278,325,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Nelson Labs | 60,655,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Nordion | 49,149,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Segment | Sterigenics | 211,571,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Product | Product | 38,437,000 | USD | 0001822479-26-000031 |
| Q1 2026Quarterly · 2026-03-31 | Product | Services | 241,608,000 | USD | 0001822479-26-000031 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Nelson Labs | 51,901,000 | USD | 0001822479-26-000031 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Nordion | 42,009,000 | USD | 0001822479-26-000031 |
| Q1 2026Quarterly · 2026-03-31 | Segment | Sterigenics | 186,135,000 | USD | 0001822479-26-000031 |
| Q4 2025Quarterly · 2025-12-31 | Product | Product | 44,398,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Services | 259,043,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Nelson Labs | 55,204,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Nordion | 49,825,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Segment | Sterigenics | 198,412,000 | USD | Legacy provider |
| FY 2025Yearly · 2025-12-31 | Geography | Canada | 221,948,000 | USD | 0001822479-26-000015 |
| FY 2025Yearly · 2025-12-31 | Geography | Europe | 232,179,000 | USD | 0001822479-26-000015 |
| FY 2025Yearly · 2025-12-31 | Geography | Other Geographical Areas | 79,947,000 | USD | 0001822479-26-000015 |
| FY 2025Yearly · 2025-12-31 | Geography | United States | 629,543,000 | USD | 0001822479-26-000015 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 167,861,000 | USD | 0001822479-26-000015 |
| FY 2025Yearly · 2025-12-31 | Product | Services | 995,756,000 | USD | 0001822479-26-000015 |
| FY 2025Yearly · 2025-12-31 | Segment | Nelson Labs | 220,219,000 | USD | 0001822479-26-000015 |
| FY 2025Yearly · 2025-12-31 | Segment | Nordion | 187,618,000 | USD | 0001822479-26-000015 |
| FY 2025Yearly · 2025-12-31 | Segment | Sterigenics | 755,780,000 | USD | 0001822479-26-000015 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 55,783,000 | USD | 0001822479-25-000054 |
| Q3 2025Quarterly · 2025-09-30 | Product | Services | 255,529,000 | USD | 0001822479-25-000054 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Nelson Labs | 55,662,000 | USD | 0001822479-25-000054 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Nordion | 62,805,000 | USD | 0001822479-25-000054 |
| Q3 2025Quarterly · 2025-09-30 | Segment | Sterigenics | 192,845,000 | USD | 0001822479-25-000054 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 37,097,000 | USD | 0001822479-25-000044 |
| Q2 2025Quarterly · 2025-06-30 | Product | Services | 257,244,000 | USD | 0001822479-25-000044 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Nelson Labs | 57,071,000 | USD | 0001822479-25-000044 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Nordion | 42,431,000 | USD | 0001822479-25-000044 |
| Q2 2025Quarterly · 2025-06-30 | Segment | Sterigenics | 194,839,000 | USD | 0001822479-25-000044 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 30,583,000 | USD | 0001822479-26-000031 |
| Q1 2025Quarterly · 2025-03-31 | Product | Services | 223,940,000 | USD | 0001822479-26-000031 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Nelson Labs | 52,282,000 | USD | 0001822479-26-000031 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Nordion | 32,557,000 | USD | 0001822479-26-000031 |
| Q1 2025Quarterly · 2025-03-31 | Segment | Sterigenics | 169,684,000 | USD | 0001822479-26-000031 |
| Q4 2024Quarterly · 2024-12-31 | Product | Product | 51,408,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Services | 238,795,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Nelson Labs | 53,984,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Nordion | 56,791,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Segment | Sterigenics | 179,428,000 | USD | Legacy provider |
| FY 2024Yearly · 2024-12-31 | Geography | Canada | 208,886,000 | USD | 0001822479-26-000015 |
| FY 2024Yearly · 2024-12-31 | Geography | Europe | 196,011,000 | USD | 0001822479-26-000015 |
| FY 2024Yearly · 2024-12-31 | Geography | Other Geographical Areas | 78,860,000 | USD | 0001822479-26-000015 |
| FY 2024Yearly · 2024-12-31 | Geography | United States | 616,684,000 | USD | 0001822479-26-000015 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 158,619,000 | USD | 0001822479-26-000015 |
| FY 2024Yearly · 2024-12-31 | Product | Services | 941,822,000 | USD | 0001822479-26-000015 |
| FY 2024Yearly · 2024-12-31 | Segment | Nelson Labs | 229,233,000 | USD | 0001822479-26-000015 |
| FY 2024Yearly · 2024-12-31 | Segment | Nordion | 173,355,000 | USD | 0001822479-26-000015 |
| FY 2024Yearly · 2024-12-31 | Segment | Sterigenics | 697,853,000 | USD | 0001822479-26-000015 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 46,678,000 | USD | 0001822479-25-000054 |
| Q3 2024Quarterly · 2024-09-30 | Product | Services | 238,790,000 | USD | 0001822479-25-000054 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Nelson Labs | 58,581,000 | USD | 0001822479-25-000054 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Nordion | 51,313,000 | USD | 0001822479-25-000054 |
| Q3 2024Quarterly · 2024-09-30 | Segment | Sterigenics | 175,574,000 | USD | 0001822479-25-000054 |
| FY 2023Yearly · 2023-12-31 | Geography | Canada | 192,050,000 | USD | 0001822479-26-000015 |
| FY 2023Yearly · 2023-12-31 | Geography | Europe | 187,542,000 | USD | 0001822479-26-000015 |
| FY 2023Yearly · 2023-12-31 | Geography | Other Geographical Areas | 78,729,000 | USD | 0001822479-26-000015 |
| FY 2023Yearly · 2023-12-31 | Geography | United States | 590,967,000 | USD | 0001822479-26-000015 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 143,690,000 | USD | 0001822479-26-000015 |
| FY 2023Yearly · 2023-12-31 | Product | Services | 905,598,000 | USD | 0001822479-26-000015 |
| FY 2023Yearly · 2023-12-31 | Segment | Nelson Labs | 221,699,000 | USD | 0001822479-26-000015 |
| FY 2023Yearly · 2023-12-31 | Segment | Nordion | 160,459,000 | USD | 0001822479-26-000015 |
| FY 2023Yearly · 2023-12-31 | Segment | Sterigenics | 667,130,000 | USD | 0001822479-26-000015 |
| FY 2022Yearly · 2022-12-31 | Geography | Canada | 188,741,000 | USD | 0001822479-25-000015 |
| FY 2022Yearly · 2022-12-31 | Geography | Europe | 166,025,000 | USD | 0001822479-25-000015 |
| FY 2022Yearly · 2022-12-31 | Geography | Other Geographical Areas | 69,903,000 | USD | 0001822479-25-000015 |
| FY 2022Yearly · 2022-12-31 | Geography | United States | 579,018,000 | USD | 0001822479-25-000015 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 138,859,000 | USD | 0001822479-25-000015 |
| FY 2022Yearly · 2022-12-31 | Product | Services | 864,828,000 | USD | 0001822479-25-000015 |
| FY 2022Yearly · 2022-12-31 | Segment | Nelson Labs | 223,402,000 | USD | 0001822479-25-000015 |
| FY 2022Yearly · 2022-12-31 | Segment | Nordion | 153,639,000 | USD | 0001822479-25-000015 |
| FY 2022Yearly · 2022-12-31 | Segment | Sterigenics | 626,646,000 | USD | 0001822479-25-000015 |
| FY 2021Yearly · 2021-12-31 | Geography | Canada | 177,875,000 | USD | 0001822479-24-000011 |
| FY 2021Yearly · 2021-12-31 | Geography | Europe | 161,810,000 | USD | 0001822479-24-000011 |
| FY 2021Yearly · 2021-12-31 | Geography | Other Geographical Areas | 63,886,000 | USD | 0001822479-24-000011 |
| FY 2021Yearly · 2021-12-31 | Geography | United States | 527,907,000 | USD | 0001822479-24-000011 |
| FY 2021Yearly · 2021-12-31 | Product | Product | 125,977,000 | USD | 0001822479-24-000011 |
| FY 2021Yearly · 2021-12-31 | Product | Services | 805,501,000 | USD | 0001822479-24-000011 |
| FY 2021Yearly · 2021-12-31 | Segment | Nelson Labs | 219,142,000 | USD | 0001822479-24-000011 |
| FY 2021Yearly · 2021-12-31 | Segment | Nordion | 140,507,000 | USD | 0001822479-24-000011 |
| FY 2021Yearly · 2021-12-31 | Segment | Sterigenics | 571,829,000 | USD | 0001822479-24-000011 |
| FY 2020Yearly · 2020-12-31 | Geography | Canada | 135,938,000 | USD | 0001822479-23-000015 |
| FY 2020Yearly · 2020-12-31 | Geography | Europe | 135,720,000 | USD | 0001822479-23-000015 |
| FY 2020Yearly · 2020-12-31 | Geography | Other Geographical Areas | 56,002,000 | USD | 0001822479-23-000015 |
| FY 2020Yearly · 2020-12-31 | Geography | United States | 490,498,000 | USD | 0001822479-23-000015 |
| FY 2020Yearly · 2020-12-31 | Product | Product | 104,638,000 | USD | 0001822479-23-000015 |
| FY 2020Yearly · 2020-12-31 | Product | Services | 713,520,000 | USD | 0001822479-23-000015 |
| FY 2020Yearly · 2020-12-31 | Segment | Nelson Labs | 204,640,000 | USD | 0001822479-23-000015 |
| FY 2020Yearly · 2020-12-31 | Segment | Nordion | 114,745,000 | USD | 0001822479-23-000015 |
| FY 2020Yearly · 2020-12-31 | Segment | Sterigenics | 498,773,000 | USD | 0001822479-23-000015 |
| FY 2019Yearly · 2019-12-31 | Geography | Canada | 130,469,000 | USD | 0001822479-22-000014 |
| FY 2019Yearly · 2019-12-31 | Geography | Europe | 122,606,000 | USD | 0001822479-22-000014 |
| FY 2019Yearly · 2019-12-31 | Geography | Other Geographical Areas | 51,294,000 | USD | 0001822479-22-000014 |
| FY 2019Yearly · 2019-12-31 | Geography | United States | 473,958,000 | USD | 0001822479-22-000014 |
| FY 2019Yearly · 2019-12-31 | Product | Product | 105,290,000 | USD | 0001822479-22-000014 |
| FY 2019Yearly · 2019-12-31 | Product | Services | 673,037,000 | USD | 0001822479-22-000014 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.